New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 6, 2014
08:38 EDTCBRXColumbia Laboratories sells IP and technology for Legatrin for $2.2M
Columbia Laboratories announced that Lil' Drug Store Products exercised its option to purchase the Intellectual Property Rights and Technology related to Legatrin P.M. Columbia licensed this product to Lil' Drug Store Products approximately fourteen years ago and has received annual royalties. Columbia will receive approximately $2.2M for the sale.
News For CBRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 18, 2015
07:03 EDTCBRXColumbia Laboratories 'actively moving forward' focused on 505b2 products
Columbia is actively moving forward as a women's health specialty pharmaceutical company focused on 505(b)2 products. The Company's next product will enter the clinic during the second quarter, and the company is active in identifying and advancing additional, promising drug candidates.
07:03 EDTCBRXColumbia Laboratories sees FY15 revenue growth in low double digits
Subscribe for More Information
07:02 EDTCBRXColumbia Laboratories reports Q4 EPS (5c), consensus 7c
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use